The Medicines and Health products Regulatory Agency (MHRA) on Monday (Jan 18) issued a drug recall for Instanyl 100mcg nasal spray solution of Takeda UK Limited.
|Product||Batch number||Expiry Date||Pack Size||First Distributed|
|Instanyl 100mcg Nasal Spray||447055||31/10/2021||1 x 6 single dose containers||14/04/2020|
Takeda is recalling the above batch of Instanyl 100mcg nasal spray solution due to “the observation of cracked vials during inspection of the bulk vials and release testing of the finished products”, the company has said in its drug alert.
The drug manufacturer has not received any reports of damage for the marketed products. “However, due to the low potential for breaking or cracking of the glass vial, which is contained within the plastic actuator casing and a potential risk of microbial contamination, the above batch is being recalled as a precautionary measure,” the company added.
Healthcare professionals have been advised to quarantine all remaining stock of the batches and return to Takeda for replacement.